Our results, showing an interactive association between PTGS2 (COX-2) and CD274 (PD-L1) expression in CRC, are consistent with prior epidemiological evidence linking these pathways to patient outcomes. The gene discussed is PTGS2; the disease is colorectal carcinoma.